|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||3.8700 - 4.2000|
|52 Week Range||0.6900 - 5.8000|
|Beta (3Y Monthly)||3.49|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Repeat performances could be in store for these big marijuana winners from last year.
From companies going public on major exchanges, mergers and acquisitions and full legalization of weed in Canada, 2018 was a transformational year in cannabis. One major milestone for the industry was the passage of the 2018 Farm Bill. The legalization of hemp and its removal from Schedule I of the Controlled Substances Act is viewed as a major step forward for the cannabis industry because it legalizes hemp-derived cannabidiol, or CBD.
Legalization, which New Jersey Governor Phil Murphy wanted in 2018, has been mired in debates over taxation and how to erase existing marijuana-related convictions. Pressure to get a deal done has grown in recent weeks as the governors of New York and Pennsylvania called for legal pot, threatening New Jersey’s bid to be the first New York City-area state to offer sales. “We would be the economic engine for the state -- there’s no question -- but right now it’s not something I could support,” said Steve Fulop, Jersey City’s mayor and a former Wall Street trader.
As the United States waits for president Trump to sign the 2018 Farm Bill before next year, cannabis operator Marimed Inc (OTCMKTS:MRMD) has made an official announcement concerning a significant investment in hemp. The statement has hailed the passing of the Bill and its becoming law soon as this is considered the official inauguration of […] The post Marimed Expects To Lead In Hemp Derived CBD Following 2018 Farm Bill Passage appeared first on Market Exclusive.
Marijuana stock investors: The market for hemp-derived CBD products is expected to balloon to $22 billion by 2022.
The cannabis industry is quickly turning into a multi-billion dollar powerhouse thanks to the drastic demand for cannabis products. Reports have it that cannabis revenues are likely to hit $9 billion by the end of the year. This kind of speculation has resulted in serious investment by various companies seeking to grab a share of […] The post Demand For Cannabis Prompts Marimed To Expand CBD Hemp Operations appeared first on Market Exclusive.
When medical cannabis became legal in Maryland last year, New Frontier Data projected 2018 sales would come in at around $46 million. When compared to other states with high median incomes, such as Hawaii, California and Massachusetts, Maryland remains a fairly inexpensive state in which to live. Marijuana is still only medically legal in Maryland, and it’s already on pace to bring in $1 million in its first year.
As the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill. Two companies that have been particularly aggressive in their pursuit of the hemp-based CBD market have been Elixinol Global Ltd. (OTCQX: ELLXF) and MariMed, Inc. (OTCQB:MRMD). Shares for the IPO were sold at $1.00 AUD per share ($0.73 USD), but the stock quickly climbed to $1.82 AUD ($1.32 USD) within the first week of trading.
When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...
A new company is set to join the growing hemp market. MariMed Inc (OTC: MRMD ) has agreed to invest $30 million in GenCanna Global as part of a strategic partnership. What Happened MariMed develops and ...
When the dust settled from the midterm elections, President Donald Trump did something both shocking and inevitable: he fired Attorney General Jeff Sessions. Occupying a contentious tenure from the start, Sessions passive-aggressively clashed with Trump by recusing himself from the Russian-meddling inquiry. Political insiders characterized Sessions as having a “tough sheriff” personality.
The legalization of medical marijuana and recreational marijuana have emerged as key talking points in the run up to the election. Seven states have already legalized recreational marijuana, while roughly 30 other states have passed medical cannabis in some form. On Tuesday, four more states could be added to those lists. Legalization of the drug for recreational use is on the ballot in North Dakota and Michigan, while voters in Missouri and Utah will decide whether to legalize cannabis for medical purposes.
U.S.-based MariMed bucked the downtrend in the cannabis sector last month. Here's what investors should know.
Naturally, this has significant implications for marijuana stocks. Favorable legislation stateside and in Canada boosted marijuana stocks like Tilray (NASDAQ:TLRY) into the stratosphere. While the pain is extremely pronounced for pot stocks, I believe the political environment presents high-risk/high-reward contrarian opportunities.
U.S. Marijuana Index, compiled by Marijuana International Corporation, has delivered 158% returns over the past one year, as of October 17, 2018. Though the market saw a lot of volatility in marijuana policy during the course of the year on account of hard line policy stance taken by the new U.